Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 3.04 is 18% below its 5-year average of 3.71, near the low end of its 5-year range (1.34–10.44).
As of the fiscal period ended Tuesday, June 30, 2026. 25.16% below its 12-month average of 4.06.
Reported quarterly current ratio; no daily interpolation. Q1 FY2027 (2026-06-30): 3.04.
CURRENT RATIO
3.04
CURRENT RATIO AVG TTM
4.06
CURRENT RATIO AVG 3Y
2.73
CURRENT RATIO AVG 5Y
3.71
CURRENT RATIO AVG 10Y
6.47
CURRENT RATIO AVG 15Y
6.31
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-25.16%
CURRENT VS 3Y AVG
+11.04%
CURRENT VS 5Y AVG
-18.15%
CURRENT VS 10Y AVG
-53.06%
CURRENT VS 15Y AVG
-51.86%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.58
median of 744 covered companies
CURRENT VS SECTOR MEDIAN
-15.18%
vs the sector median at left
Canopy Growth Corporation
Market Cap
$373.86M
Current Ratio
3.04
TTM Avg
4.06
3Y Avg
2.73
5Y Avg
3.71
Market Cap
$378.17M
Current Ratio
5.88
TTM Avg
5.65
3Y Avg
4.80
5Y Avg
5.41
Market Cap
$384.40M
Current Ratio
9.06
TTM Avg
8.18
3Y Avg
5.96
5Y Avg
5.74
Market Cap
$356.41M
Current Ratio
24.16
TTM Avg
12.00
3Y Avg
8.65
5Y Avg
7.93
Market Cap
$355.77M
Current Ratio
5.85
TTM Avg
6.36
3Y Avg
5.52
5Y Avg
8.17
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Canopy Growth Corporation (CGC) | $373.86M | 3.04 | 4.06 | 2.73 | 3.71 |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $378.17M | 5.88 | 5.65 | 4.80 | 5.41 |
| Opus Genetics, Inc. (IRD)vs › | $364.53M | 12.19 | 4.83 | 10.20 | 8.85 |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $384.40M | 9.06 | 8.18 | 5.96 | 5.74 |
| Orthofix Medical Inc. (OFIX)vs › | $386.23M | 2.84 | 2.51 | 2.66 | 2.63 |
| Ocugen, Inc. (OCGN)vs › | $359.46M | 0.80 | 1.96 | 2.47 | 5.28 |
| Embecta Corp. (EMBC)vs › | $356.86M | 1.68 | 2.22 | 2.19 | 2.04 |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $356.41M | 24.16 | 12.00 | 8.65 | 7.93 |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $355.77M | 5.85 | 6.36 | 5.52 | 8.17 |
| REGENXBIO Inc. (RGNX)vs › | $393.42M | 2.86 | 2.54 | 2.71 | 3.55 |
Current Ratio
3.04
Quick Ratio
2.39
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 3.04 |
| 2026-03-31 | 3.34 |
| 2025-12-31 | 5.34 |
| 2025-09-30 | 5.50 |
| 2025-06-30 | 3.07 |
| 2025-03-31 | 3.12 |
| 2024-12-31 | 3.52 |
| 2024-09-30 | 1.39 |
| 2024-06-30 | 2.15 |
| 2024-03-31 | 1.58 |
| 2023-12-31 | 1.79 |
| 2023-09-30 | 2.52 |
| 2023-06-30 | 1.96 |
| 2023-03-31 | 1.34 |
| 2022-12-31 | 1.73 |
| 2022-09-30 | 2.84 |
| 2022-06-30 | 3.94 |
| 2022-03-31 | 8.10 |
| 2021-12-31 | 8.31 |
| 2021-09-30 | 9.63 |
| 2021-06-30 | 10.44 |
| 2021-03-31 | 9.98 |
| 2020-12-31 | 6.24 |
| 2020-09-30 | 7.06 |
| 2020-06-30 | 8.18 |
| 2020-03-31 | 6.10 |
| 2019-12-31 | 7.58 |
| 2019-09-30 | 8.38 |
| 2019-06-30 | 10.37 |
| 2019-03-31 | 11.95 |
| 2018-12-31 | 17.85 |
| 2018-09-30 | 0.64 |
| 2018-06-30 | 6.84 |
| 2018-03-31 | 5.24 |
| 2017-12-31 | 12.80 |
| 2017-09-30 | 10.50 |
| 2017-06-30 | 13.16 |
| 2017-03-31 | 10.12 |
| 2016-12-31 | 10.88 |
| 2016-09-30 | 10.13 |
| 2016-06-30 | 6.59 |
| 2016-03-31 | 6.23 |
| 2015-12-31 | 9.93 |
| 2015-09-30 | 4.23 |
| 2015-06-30 | 5.56 |
| 2015-03-31 | 6.49 |
| 2014-12-31 | 3.75 |
| 2014-09-30 | 5.58 |
| 2014-06-30 | 4.91 |
| 2014-03-31 | 3.45 |
| 2014-01-31 | 190.31 |
| 2013-10-31 | 45.30 |
| 2013-07-31 | 47.00 |
| 2013-04-30 | 300.62 |
| 2013-01-31 | 362.40 |
| 2012-10-31 | 81.95 |
| 2012-07-31 | 59.67 |
| 2012-04-30 | 83.97 |
| 2012-01-31 | 50.84 |
| 2011-10-31 | 55.32 |
| 2011-07-31 | 85.18 |
| 2011-04-30 | 107.03 |
| 2011-01-31 | 145.71 |
| 2010-10-31 | 160.16 |
| 2010-07-31 | 77.06 |
| 2010-04-30 | 6.33 |
| 2010-01-31 | 0.00 |
